- Laboratory >
- Immunology >
- Rapid fluorescence immunoassay test >
- LumiraDx
LumiraDx rapid fluorescence immunoassay tests
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Result display time: 5 min
... the LumiraDx SARS-CoV-2 Ag Ultra test enables you to accurately and confidently test more patients, optimize clinic workflows and help triage patients without delay. Test benefits Microfluidic ...
LumiraDx
Result display time: 12 min
... near-patient testing Minimal handling steps Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test ...
LumiraDx
Result display time: 11 min
Sensitivity: 84.6 % - 100 %
... infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care. Test benefits The LumiraDx SARS-CoV-2 Ab Test is designed to be ...
LumiraDx
Result display time: 5 min
... Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run. Test ...
LumiraDx
Result display time: 12 min
... for pre entry or reopening of sites Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning ...
LumiraDx
Result display time: 12 min
... -Cov-2 & Flu A/B Test Easy to implement at point of care No refrigeration storage required: room temperature storage (2-30°C) Minimal handling steps Small and portable Instrument Test workflow The ...
LumiraDx
Your suggestions for improvement:
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining